<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:a641eb09-3149-42a1-b1fd-1f3a5f7428a1,g:e030e3eb-cc79-402d-996f-7d3fa56fdfa0-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.madrigalpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="mdgl-20250630.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.madrigalpharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_16e99491-9354-48af-ac9c-6f092d23e08b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_07ff5fdb-436f-4c07-8ac6-520579fad24d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_16e99491-9354-48af-ac9c-6f092d23e08b" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_07ff5fdb-436f-4c07-8ac6-520579fad24d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_efca406c-0f17-4a2d-9f22-f129856df6b5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesNoncurrent_16e99491-9354-48af-ac9c-6f092d23e08b" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_efca406c-0f17-4a2d-9f22-f129856df6b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_1d2a5820-a228-4dde-9f1e-3ff0ccca378f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_b16edc0d-f74e-4cf1-a252-d41353841b05" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1d2a5820-a228-4dde-9f1e-3ff0ccca378f" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_b16edc0d-f74e-4cf1-a252-d41353841b05" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_e9524fae-4aa1-4418-878d-5dccc1d81cd2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1d2a5820-a228-4dde-9f1e-3ff0ccca378f" xlink:to="loc_us-gaap_AccountsPayableCurrent_e9524fae-4aa1-4418-878d-5dccc1d81cd2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_f03e93af-e21c-480f-abaa-dd75c6732a4a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1d2a5820-a228-4dde-9f1e-3ff0ccca378f" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_f03e93af-e21c-480f-abaa-dd75c6732a4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_a1cf2a56-5b3e-4188-800e-eb00b6276954" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_a0b65f01-882e-4da6-a45c-8fb8c0ff1d0a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_a1cf2a56-5b3e-4188-800e-eb00b6276954" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_a0b65f01-882e-4da6-a45c-8fb8c0ff1d0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_6487e525-e849-4b9d-bb94-4966d2f0f63c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_a1cf2a56-5b3e-4188-800e-eb00b6276954" xlink:to="loc_us-gaap_LiabilitiesCurrent_6487e525-e849-4b9d-bb94-4966d2f0f63c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_ff7ed164-0a30-456a-9798-aad10d74f6d5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_a324df7b-534d-4dbf-94b4-d8ace14e6e77" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_ff7ed164-0a30-456a-9798-aad10d74f6d5" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_a324df7b-534d-4dbf-94b4-d8ace14e6e77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_f9e0c52c-ded2-422f-81a6-bd3a0d997e78" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCash"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_ff7ed164-0a30-456a-9798-aad10d74f6d5" xlink:to="loc_us-gaap_RestrictedCash_f9e0c52c-ded2-422f-81a6-bd3a0d997e78" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_fdc732d2-d7eb-42a7-89ee-456a12ad2037" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_ff7ed164-0a30-456a-9798-aad10d74f6d5" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_fdc732d2-d7eb-42a7-89ee-456a12ad2037" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_ff16d8e1-3ad2-4afa-8138-2dedeafbc87f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_ff7ed164-0a30-456a-9798-aad10d74f6d5" xlink:to="loc_us-gaap_InventoryNet_ff16d8e1-3ad2-4afa-8138-2dedeafbc87f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a6981512-c99d-4d89-a50e-4b3d4c8d11bf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_ff7ed164-0a30-456a-9798-aad10d74f6d5" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a6981512-c99d-4d89-a50e-4b3d4c8d11bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d50aad0b-8d82-4d3c-a557-f4a547a11a22" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_ff7ed164-0a30-456a-9798-aad10d74f6d5" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d50aad0b-8d82-4d3c-a557-f4a547a11a22" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_906ec05b-3872-4b13-aa3f-6016c6de0309" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_b15a8a40-f925-4d7a-bdf8-e744fb41811e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_906ec05b-3872-4b13-aa3f-6016c6de0309" xlink:to="loc_us-gaap_CommonStockValue_b15a8a40-f925-4d7a-bdf8-e744fb41811e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_ede9a6a0-504d-4432-b0f2-eb7757235249" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_906ec05b-3872-4b13-aa3f-6016c6de0309" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_ede9a6a0-504d-4432-b0f2-eb7757235249" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_7b1b6d43-a843-40f7-aadb-51604371ff28" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_906ec05b-3872-4b13-aa3f-6016c6de0309" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_7b1b6d43-a843-40f7-aadb-51604371ff28" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_dba51fe3-f723-40ff-80da-0cf3457c5264" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_906ec05b-3872-4b13-aa3f-6016c6de0309" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_dba51fe3-f723-40ff-80da-0cf3457c5264" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_5425a941-84be-4983-9a16-b7429f0bf15e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_906ec05b-3872-4b13-aa3f-6016c6de0309" xlink:to="loc_us-gaap_PreferredStockValue_5425a941-84be-4983-9a16-b7429f0bf15e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_e281f055-8eab-4de9-9652-c9b40ca6f68b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b623d709-670c-4969-8615-a59892cba734" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e281f055-8eab-4de9-9652-c9b40ca6f68b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b623d709-670c-4969-8615-a59892cba734" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_4bf1ba2c-678d-4cbc-9d90-d4bcc5cedccc" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e281f055-8eab-4de9-9652-c9b40ca6f68b" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_4bf1ba2c-678d-4cbc-9d90-d4bcc5cedccc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_cb0377f9-4b12-4977-ad5d-6cfa5d78562a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e281f055-8eab-4de9-9652-c9b40ca6f68b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_cb0377f9-4b12-4977-ad5d-6cfa5d78562a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_8a205dd6-dd53-46c7-82e7-3a4c624aba46" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_e281f055-8eab-4de9-9652-c9b40ca6f68b" xlink:to="loc_us-gaap_AssetsCurrent_8a205dd6-dd53-46c7-82e7-3a4c624aba46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_632e54e3-3bcc-4de7-8c74-e3625eaa466e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_91ac98a4-3caf-41d9-b6ad-4da825dc4be0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_632e54e3-3bcc-4de7-8c74-e3625eaa466e" xlink:to="loc_us-gaap_StockholdersEquity_91ac98a4-3caf-41d9-b6ad-4da825dc4be0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_0460e3c5-6cb3-4fef-ab5a-23c34ef09ea8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_632e54e3-3bcc-4de7-8c74-e3625eaa466e" xlink:to="loc_us-gaap_Liabilities_0460e3c5-6cb3-4fef-ab5a-23c34ef09ea8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.madrigalpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="mdgl-20250630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://www.madrigalpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_03e9fadc-d317-41bf-8f5d-5a9fa94acb0f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_7804a2f9-a8f9-411b-87d7-1968c5c1b28d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_03e9fadc-d317-41bf-8f5d-5a9fa94acb0f" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_7804a2f9-a8f9-411b-87d7-1968c5c1b28d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_f8c14724-0dc3-4ae0-b5fa-998055153c35" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_03e9fadc-d317-41bf-8f5d-5a9fa94acb0f" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_f8c14724-0dc3-4ae0-b5fa-998055153c35" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_53d3b995-c780-457b-ac76-8c6eea48c87c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_03e9fadc-d317-41bf-8f5d-5a9fa94acb0f" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_53d3b995-c780-457b-ac76-8c6eea48c87c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_c0460473-a752-4fcd-8f9b-dea5e1bc6be2" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1185acb2-e8c3-4a17-bd8b-ab291d63d38f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_c0460473-a752-4fcd-8f9b-dea5e1bc6be2" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1185acb2-e8c3-4a17-bd8b-ab291d63d38f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_e02dbccd-8a42-4409-a4da-325651688397" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_c0460473-a752-4fcd-8f9b-dea5e1bc6be2" xlink:to="loc_us-gaap_OperatingExpenses_e02dbccd-8a42-4409-a4da-325651688397" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_08ac7dca-31e1-4b3b-9949-ad8b73754d57" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_ea784296-2d6a-4d4f-8289-dcfd59b63f45" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_08ac7dca-31e1-4b3b-9949-ad8b73754d57" xlink:to="loc_us-gaap_InterestExpenseNonoperating_ea784296-2d6a-4d4f-8289-dcfd59b63f45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_8cb9c0b5-d8f8-4fb9-9481-776bb4528676" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_08ac7dca-31e1-4b3b-9949-ad8b73754d57" xlink:to="loc_us-gaap_InvestmentIncomeInterest_8cb9c0b5-d8f8-4fb9-9481-776bb4528676" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_cff8e850-b830-45dd-8a9e-8245068b7a89" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_08ac7dca-31e1-4b3b-9949-ad8b73754d57" xlink:to="loc_us-gaap_OperatingIncomeLoss_cff8e850-b830-45dd-8a9e-8245068b7a89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_c6dc1114-a9a8-4b91-9aa1-42e3eda92480" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_08ac7dca-31e1-4b3b-9949-ad8b73754d57" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_c6dc1114-a9a8-4b91-9aa1-42e3eda92480" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.madrigalpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" xlink:type="simple" xlink:href="mdgl-20250630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"/>
  <link:calculationLink xlink:role="http://www.madrigalpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_5a8b3201-89a3-4da7-8c2a-446451194ad0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_d9e987dc-6f22-4cfc-bfe0-923c7ccfab96" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_5a8b3201-89a3-4da7-8c2a-446451194ad0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_d9e987dc-6f22-4cfc-bfe0-923c7ccfab96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_7eb757b7-e18d-4164-89ba-f3103edc6c86" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_5a8b3201-89a3-4da7-8c2a-446451194ad0" xlink:to="loc_us-gaap_NetIncomeLoss_7eb757b7-e18d-4164-89ba-f3103edc6c86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_8e7806d2-cc83-4eae-b922-8c68b031a12d" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_5a8b3201-89a3-4da7-8c2a-446451194ad0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_8e7806d2-cc83-4eae-b922-8c68b031a12d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.madrigalpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="mdgl-20250630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.madrigalpharma.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ccd819ad-b5e4-416e-bba2-940974c61997" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_aa7748f5-28f0-46b8-a895-c8161c97a2fd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOrSaleOfEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ccd819ad-b5e4-416e-bba2-940974c61997" xlink:to="loc_us-gaap_ProceedsFromIssuanceOrSaleOfEquity_aa7748f5-28f0-46b8-a895-c8161c97a2fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7fe6aea5-dabf-4e8c-b204-64781a292016" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_b47a9d90-8dcd-4303-90c8-bb90744ff32e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7fe6aea5-dabf-4e8c-b204-64781a292016" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_b47a9d90-8dcd-4303-90c8-bb90744ff32e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_a921d5ac-1772-4a20-97d1-2ee5e9c12d8f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7fe6aea5-dabf-4e8c-b204-64781a292016" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_a921d5ac-1772-4a20-97d1-2ee5e9c12d8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_5700c7bb-b07e-4830-8095-20284434d2bd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7fe6aea5-dabf-4e8c-b204-64781a292016" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_5700c7bb-b07e-4830-8095-20284434d2bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_ecd04009-a073-45c5-801b-c56491002109" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_7fe6aea5-dabf-4e8c-b204-64781a292016" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_ecd04009-a073-45c5-801b-c56491002109" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_dd0a5737-78f2-4fcd-b986-bba74d1dd9d8" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9894b6dd-6d2f-4564-b716-02f98ca50163" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_dd0a5737-78f2-4fcd-b986-bba74d1dd9d8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9894b6dd-6d2f-4564-b716-02f98ca50163" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_45329e38-bfd4-4e02-801f-552641216690" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_dd0a5737-78f2-4fcd-b986-bba74d1dd9d8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_45329e38-bfd4-4e02-801f-552641216690" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_34727dd2-5b83-4548-8641-9440f41f1e95" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_dd0a5737-78f2-4fcd-b986-bba74d1dd9d8" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_34727dd2-5b83-4548-8641-9440f41f1e95" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e8a8bf39-4118-42e1-9e50-4d9438ea3622" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_6642965c-f4c2-4781-b8ae-30f0fa0999c6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayableTrade"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e8a8bf39-4118-42e1-9e50-4d9438ea3622" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableTrade_6642965c-f4c2-4781-b8ae-30f0fa0999c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_b6844fd2-14d6-4cf5-8cdc-5496396c654a" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e8a8bf39-4118-42e1-9e50-4d9438ea3622" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_b6844fd2-14d6-4cf5-8cdc-5496396c654a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdgl_IncreaseDecreaseInAccruedInterestNetOfInterestReceived_ebd29250-007d-4aa0-92a9-0c2f40fccf0b" xlink:href="mdgl-20250630.xsd#mdgl_IncreaseDecreaseInAccruedInterestNetOfInterestReceived"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e8a8bf39-4118-42e1-9e50-4d9438ea3622" xlink:to="loc_mdgl_IncreaseDecreaseInAccruedInterestNetOfInterestReceived_ebd29250-007d-4aa0-92a9-0c2f40fccf0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_e139d7cd-1e25-412b-8b78-dd88cefa5de6" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e8a8bf39-4118-42e1-9e50-4d9438ea3622" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_e139d7cd-1e25-412b-8b78-dd88cefa5de6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_044d603d-b0b0-46c6-bf0d-71f2ff7bb64c" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e8a8bf39-4118-42e1-9e50-4d9438ea3622" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_044d603d-b0b0-46c6-bf0d-71f2ff7bb64c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_3091e9fc-3cb9-46d7-8bf8-7e52a2fbb6cd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e8a8bf39-4118-42e1-9e50-4d9438ea3622" xlink:to="loc_us-gaap_ProfitLoss_3091e9fc-3cb9-46d7-8bf8-7e52a2fbb6cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_a3f255e3-26a0-4a55-b18f-1c02dcbcd5f9" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e8a8bf39-4118-42e1-9e50-4d9438ea3622" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_a3f255e3-26a0-4a55-b18f-1c02dcbcd5f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_20972333-298c-46b2-830b-f3aa36052863" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e8a8bf39-4118-42e1-9e50-4d9438ea3622" xlink:to="loc_us-gaap_ShareBasedCompensation_20972333-298c-46b2-830b-f3aa36052863" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_c86b405f-e0a3-4992-8d46-c305867befeb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e8a8bf39-4118-42e1-9e50-4d9438ea3622" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_c86b405f-e0a3-4992-8d46-c305867befeb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_c7419da6-06fc-4133-b176-7f5682979639" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e8a8bf39-4118-42e1-9e50-4d9438ea3622" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_c7419da6-06fc-4133-b176-7f5682979639" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdgl_OperatingLeaseRightOfUseAssetPeriodicReductionIncrease_1ddecc2e-eb6e-4b5a-97de-78fa24ab3fb5" xlink:href="mdgl-20250630.xsd#mdgl_OperatingLeaseRightOfUseAssetPeriodicReductionIncrease"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e8a8bf39-4118-42e1-9e50-4d9438ea3622" xlink:to="loc_mdgl_OperatingLeaseRightOfUseAssetPeriodicReductionIncrease_1ddecc2e-eb6e-4b5a-97de-78fa24ab3fb5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_36d98591-cb5b-4c08-955a-a4a3fdfa8f89" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e8a8bf39-4118-42e1-9e50-4d9438ea3622" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_36d98591-cb5b-4c08-955a-a4a3fdfa8f89" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.madrigalpharma.com/role/CashCashEquivalentsRestrictedCashandMarketableSecuritiesScheduleofCashCashEquivalentsandAvailableforSaleMarketableSecuritiesDetails" xlink:type="simple" xlink:href="mdgl-20250630.xsd#CashCashEquivalentsRestrictedCashandMarketableSecuritiesScheduleofCashCashEquivalentsandAvailableforSaleMarketableSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.madrigalpharma.com/role/CashCashEquivalentsRestrictedCashandMarketableSecuritiesScheduleofCashCashEquivalentsandAvailableforSaleMarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_fa2eec0e-4ed2-413c-bc4d-792fc53ecf4e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_17838011-cdd9-4375-833b-db98259c1d57" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_fa2eec0e-4ed2-413c-bc4d-792fc53ecf4e" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_17838011-cdd9-4375-833b-db98259c1d57" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_8ac46871-e86e-4e24-9e64-4f49534ad1b0" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_fa2eec0e-4ed2-413c-bc4d-792fc53ecf4e" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_8ac46871-e86e-4e24-9e64-4f49534ad1b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_b5dd7cd3-418d-4885-ae49-207fb2e88476" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_d4ce81e1-1343-494b-b033-eca6ff089e7e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_b5dd7cd3-418d-4885-ae49-207fb2e88476" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_d4ce81e1-1343-494b-b033-eca6ff089e7e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ec0c2ce6-76c1-408c-aa83-546bb64f474f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_b5dd7cd3-418d-4885-ae49-207fb2e88476" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_ec0c2ce6-76c1-408c-aa83-546bb64f474f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_3266976a-2e26-4b33-b519-19e2a25db1c5" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_b5dd7cd3-418d-4885-ae49-207fb2e88476" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_3266976a-2e26-4b33-b519-19e2a25db1c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdgl_CashCashEquivalentsAndShortTermInvestmentsAtCost_1104e4b1-bb17-4079-92b4-1048c7a2223b" xlink:href="mdgl-20250630.xsd#mdgl_CashCashEquivalentsAndShortTermInvestmentsAtCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_38cd655e-efff-4b50-9e13-edd85831e428" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdgl_CashCashEquivalentsAndShortTermInvestmentsAtCost_1104e4b1-bb17-4079-92b4-1048c7a2223b" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_38cd655e-efff-4b50-9e13-edd85831e428" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdgl_CashCashEquivalentAndRestrictedCash_a12b5135-9a9a-41a8-8a51-07ab0b3a7a3d" xlink:href="mdgl-20250630.xsd#mdgl_CashCashEquivalentAndRestrictedCash"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdgl_CashCashEquivalentsAndShortTermInvestmentsAtCost_1104e4b1-bb17-4079-92b4-1048c7a2223b" xlink:to="loc_mdgl_CashCashEquivalentAndRestrictedCash_a12b5135-9a9a-41a8-8a51-07ab0b3a7a3d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.madrigalpharma.com/role/CashCashEquivalentsRestrictedCashandMarketableSecuritiesScheduleofCashCashEquivalentsandAvailableforSaleMarketableSecuritiesDetails_1" xlink:type="simple" xlink:href="mdgl-20250630.xsd#CashCashEquivalentsRestrictedCashandMarketableSecuritiesScheduleofCashCashEquivalentsandAvailableforSaleMarketableSecuritiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.madrigalpharma.com/role/CashCashEquivalentsRestrictedCashandMarketableSecuritiesScheduleofCashCashEquivalentsandAvailableforSaleMarketableSecuritiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_mdgl_CashCashEquivalentsAndShortTermInvestmentsAtCost_c1ce4707-a8da-4388-a99d-ec886fae75be" xlink:href="mdgl-20250630.xsd#mdgl_CashCashEquivalentsAndShortTermInvestmentsAtCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_386a97a4-fd3d-41c1-8d20-54927d5fde89" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdgl_CashCashEquivalentsAndShortTermInvestmentsAtCost_c1ce4707-a8da-4388-a99d-ec886fae75be" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_386a97a4-fd3d-41c1-8d20-54927d5fde89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_431ce7f7-9a18-44b2-8903-3222d71845bf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdgl_CashCashEquivalentsAndShortTermInvestmentsAtCost_c1ce4707-a8da-4388-a99d-ec886fae75be" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_431ce7f7-9a18-44b2-8903-3222d71845bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_469cabe7-8f1b-4600-ab8d-4bd996975735" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_mdgl_CashCashEquivalentsAndShortTermInvestmentsAtCost_c1ce4707-a8da-4388-a99d-ec886fae75be" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_469cabe7-8f1b-4600-ab8d-4bd996975735" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.madrigalpharma.com/role/InventoryDetails" xlink:type="simple" xlink:href="mdgl-20250630.xsd#InventoryDetails"/>
  <link:calculationLink xlink:role="http://www.madrigalpharma.com/role/InventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_523b60f9-0ae0-4aa4-a165-723a638473ad" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_f49a69f9-4482-4f54-91c1-d150c0c0afd3" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_523b60f9-0ae0-4aa4-a165-723a638473ad" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_f49a69f9-4482-4f54-91c1-d150c0c0afd3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_740ec932-9fdc-4270-a898-834cf7b73cbb" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_523b60f9-0ae0-4aa4-a165-723a638473ad" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_740ec932-9fdc-4270-a898-834cf7b73cbb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_5db60ee9-7bef-4766-bad3-b500c9f91189" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_523b60f9-0ae0-4aa4-a165-723a638473ad" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_5db60ee9-7bef-4766-bad3-b500c9f91189" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.madrigalpharma.com/role/AccruedLiabilitiesDetails" xlink:type="simple" xlink:href="mdgl-20250630.xsd#AccruedLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.madrigalpharma.com/role/AccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_a4cf0d4d-3432-4605-9ab1-89246985e947" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_254ebdff-3f13-4822-88ba-2b8d48cefadd" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_a4cf0d4d-3432-4605-9ab1-89246985e947" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_254ebdff-3f13-4822-88ba-2b8d48cefadd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdgl_AccruedLiabilitiesGross_3659b1c8-70cd-4277-baef-4a927cb632b8" xlink:href="mdgl-20250630.xsd#mdgl_AccruedLiabilitiesGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_a4cf0d4d-3432-4605-9ab1-89246985e947" xlink:to="loc_mdgl_AccruedLiabilitiesGross_3659b1c8-70cd-4277-baef-4a927cb632b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdgl_AccruedOtherClinicalStudyRelatedCostsCurrent_11fdfc5d-c015-4cb9-96b3-1c4192ba5e81" xlink:href="mdgl-20250630.xsd#mdgl_AccruedOtherClinicalStudyRelatedCostsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_a4cf0d4d-3432-4605-9ab1-89246985e947" xlink:to="loc_mdgl_AccruedOtherClinicalStudyRelatedCostsCurrent_11fdfc5d-c015-4cb9-96b3-1c4192ba5e81" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_19972d15-6ffb-42a7-94f4-267be39e90f7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_a4cf0d4d-3432-4605-9ab1-89246985e947" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_19972d15-6ffb-42a7-94f4-267be39e90f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_6d3293fc-2b01-47d9-8fa5-939b1bd7647e" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_a4cf0d4d-3432-4605-9ab1-89246985e947" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_6d3293fc-2b01-47d9-8fa5-939b1bd7647e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdgl_AccruedContractResearchCostsCurrent_9909196e-762b-41a4-9a89-585a00c7a092" xlink:href="mdgl-20250630.xsd#mdgl_AccruedContractResearchCostsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_a4cf0d4d-3432-4605-9ab1-89246985e947" xlink:to="loc_mdgl_AccruedContractResearchCostsCurrent_9909196e-762b-41a4-9a89-585a00c7a092" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdgl_AccruedManufacturingAndDrugSupplyCurrent_5ecaa9c6-2b34-4db8-ac37-f2d3390b338e" xlink:href="mdgl-20250630.xsd#mdgl_AccruedManufacturingAndDrugSupplyCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_a4cf0d4d-3432-4605-9ab1-89246985e947" xlink:to="loc_mdgl_AccruedManufacturingAndDrugSupplyCurrent_5ecaa9c6-2b34-4db8-ac37-f2d3390b338e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.madrigalpharma.com/role/LongTermDebtScheduleofMaturitiesofLongTermDebtDetails" xlink:type="simple" xlink:href="mdgl-20250630.xsd#LongTermDebtScheduleofMaturitiesofLongTermDebtDetails"/>
  <link:calculationLink xlink:role="http://www.madrigalpharma.com/role/LongTermDebtScheduleofMaturitiesofLongTermDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_4c27fe37-783f-4ee5-8146-968adb354516" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_ea65e206-4fd6-4df6-b19f-f8736dd20051" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_4c27fe37-783f-4ee5-8146-968adb354516" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_ea65e206-4fd6-4df6-b19f-f8736dd20051" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_0a12bd57-c249-4b4e-ba3c-dd4538ecba4b" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_4c27fe37-783f-4ee5-8146-968adb354516" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_0a12bd57-c249-4b4e-ba3c-dd4538ecba4b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_fa6ef11a-74ba-49f5-8484-1dd2276f9dcf" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_4c27fe37-783f-4ee5-8146-968adb354516" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_fa6ef11a-74ba-49f5-8484-1dd2276f9dcf" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.madrigalpharma.com/role/SegmentInformationScheduleofSegmentInformationDetails" xlink:type="simple" xlink:href="mdgl-20250630.xsd#SegmentInformationScheduleofSegmentInformationDetails"/>
  <link:calculationLink xlink:role="http://www.madrigalpharma.com/role/SegmentInformationScheduleofSegmentInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_83360b2c-653f-4cbc-8fb1-2d08791327b7" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4fc9a295-824c-48e2-ad7e-2b9689926807" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_83360b2c-653f-4cbc-8fb1-2d08791327b7" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4fc9a295-824c-48e2-ad7e-2b9689926807" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpenses_6648c8dd-e689-4dd9-a6ef-849a4bc65d78" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingCostsAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_83360b2c-653f-4cbc-8fb1-2d08791327b7" xlink:to="loc_us-gaap_OperatingCostsAndExpenses_6648c8dd-e689-4dd9-a6ef-849a4bc65d78" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdgl_ResearchAndDevelopmentExpensePersonnelAndInternal_6e000622-6717-4d78-bf57-696ea3b65eb9" xlink:href="mdgl-20250630.xsd#mdgl_ResearchAndDevelopmentExpensePersonnelAndInternal"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_83360b2c-653f-4cbc-8fb1-2d08791327b7" xlink:to="loc_mdgl_ResearchAndDevelopmentExpensePersonnelAndInternal_6e000622-6717-4d78-bf57-696ea3b65eb9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_mdgl_ResearchAndDevelopmentExternalExpense_dc7f357b-6131-45c2-b659-57952aae96ae" xlink:href="mdgl-20250630.xsd#mdgl_ResearchAndDevelopmentExternalExpense"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_83360b2c-653f-4cbc-8fb1-2d08791327b7" xlink:to="loc_mdgl_ResearchAndDevelopmentExternalExpense_dc7f357b-6131-45c2-b659-57952aae96ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_e095b284-049e-46aa-be45-2235d3ab2506" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_83360b2c-653f-4cbc-8fb1-2d08791327b7" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_e095b284-049e-46aa-be45-2235d3ab2506" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_8883024c-40de-4479-ae8f-67ce0402796f" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_83360b2c-653f-4cbc-8fb1-2d08791327b7" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_8883024c-40de-4479-ae8f-67ce0402796f" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
